PVCT
PROVECTUS BIOPHARMACEUTICALS, INC.
Key Financials
Operating Income
$-5294765
↓ 16.8%
Gross Profit
$24541
0.0%
Net Income
$-5430851
↓ 14.8%
Total Assets
$697502.00
↓ 30.7%
EPS (Diluted)
$-0.01
0.0%
Total Liabilities
$7.0M
↑ 0.4%
Revenue
$336108
↓ 45.5%
Shareholders' Equity
$-6298737.00
↓ 5.7%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 4 | 4/6/2026 | View on SEC |
| 4 | 3/26/2026 | View on SEC |
| 10-K | 3/26/2026 | View on SEC |
| 4 | 3/20/2026 | View on SEC |
| 4 | 3/16/2026 | View on SEC |
| 4 | 3/6/2026 | View on SEC |
| 4 | 2/27/2026 | View on SEC |
| 4 | 2/23/2026 | View on SEC |
| 4 | 2/23/2026 | View on SEC |
| 4 | 2/17/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | PVCT |
| Company Name | PROVECTUS BIOPHARMACEUTICALS, INC. |
| CIK | 315545 |
| Sector | Pharmaceutical Preparations |
| Industry | Non-accelerated filer Smaller reporting company |
| Exchange | OTC |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | (866) 594-5999 |